In ovarian cancer, silencing MICU1 activates PDH by stimulating the PDPhosphatase-phosphoPDH-PDH axis, resulting in increased oxygen consumption, reduced lactate production, and inhibition of clonal growth of ovarian cancer cells 57. Here, MICU1 is linked to ovarian cancer.